4195.TWO
Price:
$18.35
Market Cap:
$1.33B
Genomics BioSci & Tech. Co.,Ltd. operates as a genome sequencing company. It offers regular DNA, complex sequence, and TAF certificated sequencing services, as well as free sequencing primer and primer walking services; peptide, gene, and oligo synthesis services; and sample preparation, gene expression analysis, genotyping analysis, DNA methylation analysis, and microbial identification services. The company also provides genome level, targeted, gene regulation, and metagenomic sequencing services; third generation sequencing services; sequencing platforms and workflow; and non-invasive prenatal test, spinal muscular atrophy carrier screening, and fragile X syndrome premutation screening se...[Read more]
Industry
Biotechnology
IPO Date
2013-12-16
Stock Exchange
TWO
Ticker
4195.TWO
According to Genomics BioSci & Tech. Co.,Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -5.96. This represents a change of 61.47% compared to the average of -3.69 of the last 4 quarters.
The mean historical PE Ratio of Genomics BioSci & Tech. Co.,Ltd. over the last ten years is 321.01. The current -5.96 PE Ratio has changed -285.66% with respect to the historical average. Over the past ten years (40 quarters), 4195.TWO's PE Ratio was at its highest in in the December 2020 quarter at 911.85. The PE Ratio was at its lowest in in the June 2023 quarter at -5.42.
Average
321.01
Median
28.99
Minimum
-8.83
Maximum
1.82K
Discovering the peaks and valleys of Genomics BioSci & Tech. Co.,Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.36%
Maximum Annual PE Ratio = 1.82K
Minimum Annual Increase = -151.81%
Minimum Annual PE Ratio = -8.83
Year | PE Ratio | Change |
---|---|---|
2024 | -6.23 | -29.53% |
2023 | -8.83 | -151.81% |
2022 | 17.05 | -71.32% |
2021 | 59.46 | -96.74% |
2020 | 1.82K | 4.36% |
The current PE Ratio of Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0.66
5-year avg
377.03
10-year avg
321.01
Genomics BioSci & Tech. Co.,Ltd.’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genomics BioSci & Tech. Co.,Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Genomics BioSci & Tech. Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Genomics BioSci & Tech. Co.,Ltd.'s PE Ratio?
How is the PE Ratio calculated for Genomics BioSci & Tech. Co.,Ltd. (4195.TWO)?
What is the highest PE Ratio for Genomics BioSci & Tech. Co.,Ltd. (4195.TWO)?
What is the 3-year average PE Ratio for Genomics BioSci & Tech. Co.,Ltd. (4195.TWO)?
What is the 5-year average PE Ratio for Genomics BioSci & Tech. Co.,Ltd. (4195.TWO)?
How does the current PE Ratio for Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) compare to its historical average?